Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$41.11 USD
+0.28 (0.69%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $41.11 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | 0.78 |
EPS Last Quarter | 0.88 |
Last EPS Surprise | 1.15% |
ABR | 1.57 |
Earnings ESP
|
0.95% |
---|---|
Current Year | 3.72 |
Next Year | 4.36 |
EPS (TTM) | 3.30 |
P/E (F1) | 11.06 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 171.60M | 176.17M | 763.41M | 869.83M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 180.41M | 184.59M | 795.78M | 890.84M |
Low Estimate | 165.50M | 167.90M | 741.00M | 848.76M |
Year ago Sales | 140.02M | 145.71M | 644.40M | 763.41M |
Year over Year Growth Est. | 22.56% | 20.90% | 18.47% | 13.94% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.78 | 0.80 | 3.72 | 4.36 |
# of Estimates | 5 | 4 | 5 | 4 |
Most Recent Consensus | 0.77 | 0.78 | 3.70 | NA |
High Estimate | 0.84 | 0.86 | 3.98 | 4.44 |
Low Estimate | 0.72 | 0.70 | 3.44 | 4.23 |
Year ago EPS | 0.62 | 0.65 | 3.32 | 3.72 |
Year over Year Growth Est. | 25.81% | 23.08% | 12.05% | 17.19% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 0 | 2 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.78 | 0.80 | 3.72 | 4.36 |
7 Days Ago | 0.78 | 0.80 | 3.72 | 4.36 |
30 Days Ago | 0.73 | 0.80 | 3.71 | 4.37 |
60 Days Ago | 0.70 | 0.83 | 3.88 | 4.46 |
90 Days Ago | 0.70 | 0.83 | 3.88 | 4.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.78 | 0.82 | 3.80 | 4.37 |
Zacks Consensus Estimate | 0.78 | 0.80 | 3.72 | 4.36 |
Earnings ESP | 0.95% | 3.15% | 2.12% | 0.29% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.88 | 1.15 | 0.65 | 0.62 | NA |
Estimate | 0.87 | 0.70 | 0.57 | 0.45 | NA |
Difference | 0.01 | 0.45 | 0.08 | 0.17 | 0.18 |
Surprise | 1.15% | 64.29% | 14.04% | 37.78% | 29.32% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more